UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
R R R- R0 R1 R2 R3 R4 RA RB RC RD RE RF RG RH RI RK RM RN RO RP RQ RR RS RT RU RV RW RX RY
RS RS RS- RSB RSC RSE RSH RSN RSP RSR RSS RSV
selected terms: 5 page 1 of 1

1. (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-Octadecahydro-3',6',10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b
(UMLS (NCI) C0056789) =Organic Chemical ;
4. 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-Triazol-3-one
[A small molecule, high-affinity substance P antagonist (SPA) with antiemetic activity. Crossing the blood brain barrier, aprepitant binds selectively to the human substance P/neurokinin receptor in the central nervous system (CNS), thereby inhibiting receptor binding of endogenous substance P and substance P-induced emesis. This agent has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors. ( NCI )] (UMLS (NCI) C1176306) APREPITANT;
APREPITANT UNIDENTIFIED;
APREPITANT PREPARATION;
APREPITANT UNIDENTIFIED =Organic Chemical; Pharmacologic Substance =[GA700] ANTIEMETICS;
Unclassified Ingredients =APREPITANT 125 MG;
APREPITANT 80 MG;
APREPITANT 125MG X1/80MG X2 CAP,PKT,3
2. (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentad
[semi-synthetic macrolide antibiotic; related to erythromycin. ( CSP )] (UMLS (NCI) C0052796) =Organic Chemical; Antibiotic =macrolide antibiotic;
ERYTHROMYCIN;
[AM200] ERYTHROMYCINS/MACROLIDES;
=AZITHROMYCIN DIHYDRATE;
AZITHROMYCIN 100 MG/5ML;
AZITHROMYCIN 250 MG;
AZITHROMYCIN 200 MG/5ML;
AZITHROMYCIN 600 MG;
AZITHROMYCIN 500 MG;
5. RSR 13
[A drug that may increase the effectiveness of radiation therapy. ( NCI )] (UMLS (NCI) C0165792) =Organic Chemical; Pharmacologic Substance
3. (6R, 7S)-7-[(R)-2-Amino-2-phenylacetamido]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, Monohydrate
[A semi-synthetic, broad-spectrum, beta-lactamase resistant, second-generation cephalosporin antibiotic derived from cephasporium. The bactericidal activity of loracarbef results from the inhibition of bacterial cell wall synthesis through interference with the cross-linking of peptidoglycan units. This results in a reduction of cell wall stability and causes cell lysis. Loracarbef is more active against a variety of gram-negative organisms but less active against gram-positive pathogens compared to first-generation agents. ( NCI )] (UMLS (NCI) C0065295) =Organic Chemical; Antibiotic ;
=[AM130] BETA-LACTAMS ANTIMICROBIALS, OTHER;
Unclassified Ingredients =LORACARBEF 100 MG/5ML;
LORACARBEF 200 MG;
LORACARBEF 200 MG/5ML;
LORACARBEF 400 MG


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM